You just read:

Entest BioMedical Inc. Subsidiary Zander Therapeutics Discusses Developments in Medicinal Chemistry for Veterinary Applications of Cancer and Autoimmune Therapies Through Modulation of Checkpoint NR2F6

News provided by

Entest BioMedical Inc.

May 23, 2017, 10:34 ET